Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Padilla, Francisco
2770  Ergebnisse:
Personensuche X
?
1

Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevim..:

Hobbs, F. D. Richard ; Montgomery, Hugh ; Padilla, Francisco...
Infectious Diseases and Therapy.  13 (2024)  3 - p. 521-533 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Real-World Insights into Evolocumab Use in Patients with Hy..:

Gupta, Milan ; Wani, Rajvi J. ; Al Faraidy, Khalid...
Cardiology and Therapy.  12 (2023)  4 - p. 703-722 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Background information for the CONT workshop on sponsorship..:

Schwarcz, Andras ; Padilla, Francisco , 2023
Link: https://data.europa.eu/d..
 
?
4

Experimental instrumentation of water stage monitoring stat..:

Quezada, Victor M. ; Hernández, J-Horacio ; Miranda, Raúl...
Flow Measurement and Instrumentation.  93 (2023)  - p. 102436 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 ..:

Kijak, Gustavo H. ; Ahani, Bahar ; Arbetter, Douglas...
Infectious Diseases and Therapy.  12 (2023)  12 - p. 2691-2707 , 2023
Link: https://doi.org/10.1007/..
 
?
6

529. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Treatme..:

Richard Hobbs, F D ; Montgomery, Hugh ; Padilla, Francisco...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
7

Background information for the CONT workshop on sponsorship..:

Schwarcz, Andras ; Padilla, Francisco , 2023
Link: https://data.europa.eu/d..
 
?
8

Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) ..:

Hobbs, F. D. Richard ; Montgomery, Hugh ; Padilla, Francisco...
Infectious Diseases and Therapy.  12 (2023)  9 - p. 2269-2287 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Efficacy and safety of intramuscular administration of tixa..:

Montgomery, Hugh ; Hobbs, F D Richard ; Padilla, Francisco...
The Lancet Respiratory Medicine.  10 (2022)  10 - p. 985-996 , 2022
Link: https://doi.org/10.1016/..
 
?
10

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing..:

Richard Hobbs, F D ; Montgomery, Hugh ; Padilla, Francisco...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
11

1918. Impact of the SARS-CoV-2–Neutralizing Antibody Combin..:

Campos, Jesus Abraham Simón ; Arbetter, Douglas ; Montgomery, Hugh...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
12

1160. Treatment-Emergent Viral Variants in the Phase 3 TACK..:

Kijak, Gustavo H ; Ahani, Bahar ; Arbetter, Douglas...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
13

Incidence of injuries among lacrosse athletes: a systematic..:

Hasan, Laith K ; Shelby, Tara ; Bolia, Ioanna K...
The Physician and Sportsmedicine.  51 (2021)  2 - p. 158-165 , 2021
Link: https://doi.org/10.1080/..
 
?
14

An update on peripheral blood neurofilaments in the diagnos..:

Belli, Agustin Rodriguez ; Sierra, Minerva Mañez ; Padilla, Francisco
Journal of the Neurological Sciences.  429 (2021)  - p. 118785 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Empirical Bayesian Kriging method to evaluate inter-annual ..:

Li, Yanmei ; Hernandez, J. Horacio ; Aviles, Manuel...
Journal of Hydrology.  582 (2020)  - p. 124517 , 2020
Link: https://doi.org/10.1016/..
 
1-15